Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: We’re reading about BIO cutting ties with WuXi, EU pharma rules, and more

    The BIO industry trade group is cutting ties with China's WuXi in response to U.S. government scrutiny of the biotech and other Chinese companies.
    by Ed Silverman Mar 14, 2024 1 minute
    Source: Alex Hogan/STAT

    Rise and shine, everyone, another busy day is on the way. We can tell because the official mascots are especially enjoying the Pharmalot grounds now that spring is springing and various work crews are dotting later on biosimilars — mark your calendar for 1 p.m. ET. To prepare, we are, of course, brewing cups of stimulation. So far, our choice today is peppermint mocha. Please do join us. Meanwhile, here are few items of interest for you to peruse. We hope you have a smashing day and conquer the world. And as always, we hope you keep in touch. …

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
    When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
    STAT1 min read
    STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
    Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
    A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

    Related Books & Audiobooks